Search

Your search keyword '"Casper H.J. van Eijck"' showing total 20 results
Start Over Author "Casper H.J. van Eijck" Journal pancreatology
20 results on '"Casper H.J. van Eijck"'

2. Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up

Author

Tara M. Mackay, Judith de Vos-Geelen, Anouk E J Latenstein, Ignace H. J. T. de Hingh, Bert A. Bonsing, Johanna W. Wilmink, Lydia G. M. van der Geest, Olivier R. Busch, Marjolein Y.V. Homs, Casper H.J. van Eijck, Hjalmar C. van Santvoort, I. Quintus Molenaar, Marc G. Besselink, Hanneke W. M. van Laarhoven, Jeanin E. van Hooft, Bas Groot Koerkamp, Marco J. Bruno, Martijn W J Stommel, Gastroenterology & Hepatology, Surgery, Medical Oncology, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and Hepatology, Oncology, CCA -Cancer Center Amsterdam, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), and RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

Subjects
Change over time, medicine.medical_specialty, ENHANCED RECOVERY, SURGERY, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Disease, PREOPERATIVE BILIARY DRAINAGE, Guideline, 03 medical and health sciences, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], ADJUVANT CHEMOTHERAPY, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Multidisciplinary approach, Pancreatic cancer, medicine, FAILURE, Humans, Netherlands, Chemotherapy, Hepatology, business.industry, General surgery, Gastroenterology, Guideline compliance, CARE, medicine.disease, Cancer registry, Management, FOLFIRINOX, Pancreatic Neoplasms, GEMCITABINE, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, PANCREATICODUODENECTOMY, 030211 gastroenterology & hepatology, Guideline Adherence, business, Follow-Up Studies, Compliance
Abstract

Background: Compliance with national guidelines on pancreatic cancer management could improve patient outcomes. Early compliance with the Dutch guideline was poor. The aim was to assess compliance with this guideline during six years after publication.Materials and methods: Nationwide guideline compliance was investigated for three subsequent time periods (2012-2013 vs. 2014-2015 vs. 2016-2017) in patients with pancreatic cancer using five quality indicators in the Netherlands Cancer Registry: 1) discussion in multidisciplinary team meeting (MDT), 2) maximum 3-week interval from final MDT to start of treatment, 3) preoperative biliary drainage when bilirubin >250 mu mol/L, 4) use of adjuvant chemotherapy, and 5) chemotherapy for inoperable disease (non-metastatic and metastatic).Results: In total, 14 491 patients were included of whom 2290 (15.8%) underwent resection and 4561 (31.5%) received chemotherapy. Most quality indicators did not change over time: overall, 88.8% of patients treated with curative intent were discussed in a MDT, 42.7% were treated with curative intent within the 3-week interval, 62.7% with a resectable head tumor and bilirubin >250 mu mol/L underwent preoperative biliary drainage, 57.2% received chemotherapy after resection, and 36.6% with metastatic disease received chemotherapy. Only use of chemotherapy for non-metastatic, non-resected disease improved over time (23.4% vs. 25.6% vs. 29.7%).Conclusion: Nationwide compliance to five quality indicators for the guideline on pancreatic cancer management showed little to no improvement during six years after publication. Besides critical review of the current quality indicators, these outcomes may suggest that a nationwide implementation program is required to increase compliance to guideline recommendations. (C) 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Published
2020

3. Sensitivity of CT, MRI, and EUS-FNA/B in the preoperative workup of histologically proven left-sided pancreatic lesions

Author

Marc G. Besselink, Marjon J. van Gils, Casper H.J. van Eijck, Jeanin E. van Hooft, Lydi M.J.W. van Driel, Bas Groot Koerkamp, Quisette P. Janssen, Myrte Gorris, Femke Struik, Bram L.J. van den Broek, Surgery, Radiology & Nuclear Medicine, Gastroenterology & Hepatology, Gastroenterology and Hepatology, CCA - Imaging and biomarkers, Amsterdam Gastroenterology Endocrinology Metabolism, and CCA - Cancer Treatment and Quality of Life

Subjects
Male, Endocrinology, Diabetes and Metabolism, Sensitivity and Specificity, Left sided, Endosonography, Cystic lesion, Primary outcome, Sensitivity, SDG 3 - Good Health and Well-being, Preoperative Care, medicine, Humans, Cyst, Magnetic resonance imaging (MRI), Pancreatic lesion, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Computed tomography (CT), Aged, Hepatology, business.industry, Endoscopic ultrasonography, Gastroenterology, Middle Aged, medicine.disease, Pancreatic lesions, Magnetic Resonance Imaging, digestive system diseases, Pancreatic Neoplasms, Tissue acquisition, Female, Pancreatic Cyst, Tomography, X-Ray Computed, Nuclear medicine, business, Abdominal surgery, Preoperative imaging
Abstract

Background and objectives: Left-sided pancreatic lesions are often treated surgically. Accurate diagnostic work-up is therefore essential to prevent futile major abdominal surgery. Large series focusing specifically on the preoperative work-up of left-sided pancreatic lesions are lacking. This surgical cohort analysis describes the sensitivity of CT, MRI, and EUS-FNA/B in the diagnostic work-up of left-sided pancreatic lesions.Methods: We performed a post-hoc analysis of patients who underwent surgery for a left-sided pancreatic lesion between April 2010 and August 2017 and participated in the randomized CPR trial. Primary outcome was the sensitivity of CT, MRI, and EUS-FNA/B. Sensitivity was determined as the most likely diagnosis of each modality compared with the postoperative histopathological diagnosis. Additionally, the change in sensitivity of EUS versus EUS-FNA/B (i.e., cyst fluid analysis, and/or tissue acquisition) was measured.Results: Overall, 181 patients were included (benign: 23%, premalignant: 27%, malignant: 50%). Most patients had solid lesions (65%). Preoperative imaging included CT (86%), MRI (41%), EUS (68%). Overall, CT and EUS-FNA/B reached a sensitivity of both 71%, compared with 66% for MRI. When EUS was combined with FNA/B, sensitivity rose from 64% to 71%. For solid lesions, CT reached the highest sensitivity (75%) when compared with MRI (70%) and EUS-FNA/B (69%). For cystic lesions, EUS-FNA/B reached the highest sensitivity (75%) when compared with CT and MRI (both 62%).Conclusions: CT is the most sensitive diagnostic modality for solid and EUS-FNA/B for cystic left-sided pancreatic lesions. EUS-FNA/B was associated with an increased sensitivity when compared to EUS alone. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of IAP and EPC.

Published
2021

4. Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival

Author

Giulia Martina Cavestro, Beatrice Mohelnikova-Duchonova, Astrid Z. Johansen, John P. Neoptolemos, Chiara Corradi, Federico Canzian, Giuseppe Vanella, Martin Loos, Gabriele Capurso, Dania Bozzato, Raffaele Pezzilli, Thilo Hackert, Erika Darvasi, Pavel Vodicka, Maria Liliana Piredda, Maria Gazouli, Inna Markovna Chen, Andrea Szentesi, Paolo Giorgio Arcidiacono, Julia S. Johansen, Juozas Kupcinskas, Péter Hegyi, Matthias B. Schneider, Pavel Soucek, Renata Talar-Wojnarowska, Eithne Costello, Casper H.J. van Eijck, Daniele Campa, Manuel Gentiluomo, Francesca Tavano, Anna Caterina Milanetto, and Carsten Palnæs Hansen

Subjects
Oncology, medicine.medical_specialty, Pancreatic ductal adenocarcinoma, Hepatology, business.industry, Endocrinology, Diabetes and Metabolism, Internal medicine, Gastroenterology, Medicine, business
Published
2021

5. Characteristics of postoperative pancreatic fistula on CT scan: A multicenter cohort study

Author

F. Jasmijn Smits, Casper H.J. van Eijck, Coert Kok, Bas Groot Koerkamp, Hjalmar C. van Santvoort, Thomas L. Bollen, Quintus Molenaar, Olivier R. Busch, Marc G. Besselink, and Frank J. Wessels

Subjects
medicine.medical_specialty, Hepatology, medicine.diagnostic_test, Pancreatic fistula, business.industry, Endocrinology, Diabetes and Metabolism, Gastroenterology, medicine, Computed tomography, Radiology, medicine.disease, business, Cohort study
Published
2018

6. Preoperative risk score for pancreatic fistula after distal pancreatectomy: Derivation and multicenter external validation

Author

Giovanni Marchegiani, Ignace H. J. T. de Hingh, Salvatore Paiella, Matteo De Pastena, Claudio Bassi, Marc G. Besselink, Casper H.J. van Eijck, and Timothy H. Mungroop

Subjects
medicine.medical_specialty, Hepatology, business.industry, Endocrinology, Diabetes and Metabolism, Preoperative risk, Gastroenterology, External validation, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Pancreatic fistula, 030220 oncology & carcinogenesis, medicine, 030211 gastroenterology & hepatology, Derivation, Radiology, Distal pancreatectomy, business
Published
2017

7. The PANcreatic DISEASE ReseArch (PANDoRA) consortium: an update

Author

Federico Canzian, Ofure Obazee, Thilo Hackert, John P. Neoptolemos, Oliver Strobel, Yogesh K. Vashist, Jakob R. Izbicki, Rudolf Kaaks, Hermann Brenner, Peter Hegyi, Ugo Boggi, Luca Morelli, Franco Bambi, Gabriele Capurso, Raffaele Pezzilli, Andrea Mambrini, Cosimo Sperti, Aldo Scarpa, Angelo Andriulli, Giulia Martina Cavestro, Paolo G. Arcidiacono, Alessandro Zerbi, William Greenhalf, Timothy J. Key, Kay-Tee Khaw, Pavel Vodicka, Pavel Soucek, Beatrice Mohelnikova-Duchonova, Martin Lovecek, Ewa Malecka-Panas, Krzysztof Jamroziak, Juozas Kupcinskas, Maria Gazouli, Olivier Busch, Casper H.J. van Eijck, H. Bas Bueno-de-Mesquita, Petra H.M. Peeters, Julia S. Johansen, Natalya Gubergrits, Keitaro Matsuo, Shogo Kikuchi, and Daniele Campa

Subjects
Hepatology, Endocrinology, Diabetes and Metabolism, Gastroenterology
Published
2018

8. Contents Vol. 9, 2009

Author

Joy Chen, Tomas S Bexelius, R.M. Pickering, C.W. Imrie, Juan L. Iovanna, Lauren M. Smith, Martin E. Fernandez-Zapico, J.P. Neoptolemos, Jean-Charles Dagorn, Santhi Swaroop Vege, S. Harris, Suresh T. Chari, Derek Reighard, T.C. Khe Tran, Chung-Yu Kao, Casper H.J. van Eijck, David C. Whitcomb, Kathryn Repas, S. George, Saima Sharif, Luis A. García Rodríguez, Michael J. Levy, Randall K. Pearson, Mark Topazian, Randall E. Brand, C. Davis, C.D. Johnson, Mats Lindblad, Yu-Jen Chen, Timothy B. Gardner, D.P. Berry, Patricia Zuccaro, Rocio Lopez, Bechien U. Wu, M.E. Pasqualini, L.M. Smith, Darwin L. Conwell, Tyler Stevens, Bret T. Petersen, Marco J. Bruno, Georgios I. Papachristou, Valentin Giroux, Michael G. Sarr, Gwen Lomberk, Erin Fink, Elie Aoun, Tung-Hu Tsai, S. Sharif, Jonathan E. Clain, Rachael Diamond, Andrea Comba, R. Sutton, Chien-An Chen, Hen-Hong Chang, J. Jan B. van Lanschot, Ferga C. Gleeson, and Janette Lamb

Subjects
Hepatology, Traditional medicine, business.industry, Endocrinology, Diabetes and Metabolism, Gastroenterology, Medicine, business
Published
2009

9. Functional Changes after Pancreatoduodenectomy: Diagnosis and Treatment

Author

T. C. Khe Tran, J. Jan B. van Lanschot, Casper H.J. van Eijck, Marco J. Bruno, Surgery, and Gastroenterology & Hepatology

Subjects
medicine.medical_specialty, Duodenum, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Gastroenterology, Pancreaticoduodenectomy, Postoperative Complications, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Endocrine system, Humans, Exocrine pancreatic insufficiency, Pancreas, Hepatology, Gastric emptying, business.industry, Stomach, medicine.disease, Steatorrhea, medicine.anatomical_structure, Gastric Emptying, Quality of Life, Exocrine Pancreatic Insufficiency, medicine.symptom, Gastrointestinal function, business
Abstract

Relatively little is known about the gastrointestinal function after recovery of a pancreatoduodenectomy. This review focuses on the functional changes of the stomach, duodenum and pancreas that occur after pancreatoduodenectomy. Although the mortality in relation to pancreatoduodenectomy has decreased over the years, it remains associated with considerable morbidity, which occurs in 40-60% of patients. Physical complaints early after the operation are often caused by motility disorders, in particular delayed gastric emptying, which occurs in up to 40% of patients. During longer follow-up of these patients the occurrence of endocrine and exocrine pancreatic insufficiency becomes more predominant. Diabetes mellitus develops in 20-50% of patients after a pancreatic resection (pancreatogenic diabetes). The main presenting symptoms of exocrine insufficiency are weight loss and steatorrhea. Its presence is suspected on clinical ground and can be supported by fecal elastase-1 measurement. Exocrine insufficiency can be compensated with oral enteric-coated enzyme supplements. The quality of life issue will be addressed as an important outcome measurement after pancreaticoduodenectomy. Furthermore, the functional changes after pancreatoduodenectomy are described in detail with suggestions for diagnosis and treatment. Copyright (C) 2010 S. Karger AG, Basel and IAP

Published
2009

10. Describing Peripancreatic Collections in Severe Acute Pancreatitis Using Morphologic Terms: An International Interobserver Agreement Study

Author

Patrick C. Freeny, Karen D. Horvath, Hein G. Gooszen, John P. Neoptolemos, Peter A. Banks, John J. Hermans, Jonathan Evans, Santhi Swaroop Vege, Lars Grenacher, Koenraad J. Mortele, Michael G. Sarr, Johan S. Laméris, Hjalmar C. van Santvoort, Casper H.J. van Eijck, Thomas L. Bollen, Jens Werner, Marja A. Boermeester, Maarten S. van Leeuwen, Marc G. Besselink, David M. Hough, Other departments, Amsterdam institute for Infection and Immunity, Amsterdam Gastroenterology Endocrinology Metabolism, Surgery, Radiology and Nuclear Medicine, and Radiology & Nuclear Medicine

Subjects
medicine.medical_specialty, Scoring system, Internationality, Endocrinology, Diabetes and Metabolism, Computer assisted tomography, Disease severity, X ray computed, medicine, Humans, Pancreas, health care economics and organizations, Observer Variation, Hepatology, business.industry, Gastroenterology, bacterial infections and mycoses, medicine.disease, Pancreas abscess, digestive system diseases, humanities, Pancreatitis, Acute pancreatitis, Radiology, business, Tomography, X-Ray Computed, Pancreatic abscess
Abstract

Background/Aims: The current terminology for describing peripancreatic collections in acute pancreatitis (AP) derived from the Atlanta Symposium (e. g. pseudocyst, pancreatic abscess) has shown a very poor interobserver agreement, creating the potential for patient mismanagement. A study was undertaken to determine the interobserver agreement for a new set of morphologic terms to describe peripancreatic collections in AP. Methods: An international, interobserver agreement study was performed: 7 gastrointestinal surgeons, 2 gastroenterologists and 8 radiologists in 3 US and 5 European tertiary referral hospitals independently evaluated 55 computed tomography (CT) scans of patients with predicted severe AP. The percentage agreement [median, interquartile range (IQR)] for 9 clinically relevant morphologic terms was calculated among all reviewers, and separately among radiologists and clinicians. The percentage agreement was defined as poor (< 0.50), moderate (0.51-0.70), good (0.71-0.90), and excellent (0.91-1.00). Results: Overall agreement was good to excellent for the terms collection (percentage agreement = 1; IQR 0.68-1), relation with pancreas (1; 0.68-1), content (0.88; 0.87-1), shape (1; 0.78-1), mass effect (0.78; 0.62-1), loculated gas bubbles (1; 1-1), and air-fluid levels (1; 1-1). Overall agreement was moderate for extent of pancreatic nonenhancement (0.60; 0.46-0.88) and encapsulation (0.56; 0.48-0.69). The percentage agreement was greater among radiologists than clinicians for extent of pancreatic nonenhancement (0.75 vs. 0.57, p = 0.008), encapsulation (0.67 vs. 0.46, p = 0.001), and content (1 vs. 0.78, p = 0.008). Conclusion: Interobserver agreement for the new set of morphologic terms to describe peripancreatic collections in AP is good to excellent. Therefore, we recommend that current clinically based definitions for CT findings in AP (e. g. pancreatic abscess) should no longer be used. Copyright (C) 2008 S. Karger AG, Basel and IAP

Published
2008

11. A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer

Author

Casper H.J. van Eijck, Bassel F. El-Rayes, Ravi Shridhar, Julien Taieb, Andrea Wang-Gillam, Thierry Conroy, Jason E. Faris, Berend R. Beumer, Peter J. Allen, Bas Groot Koerkamp, Eran Sadot, Mustafa Suker, Theodore S. Hong, Lysiane Marthey, Peter J. Hosein, Jill Lacy, Florian Hohla, Sing Yu Moorcraft, Ian Chau, and Eric A. Mellon

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, FOLFIRINOX, Endocrinology, Diabetes and Metabolism, Gastroenterology, 030218 nuclear medicine & medical imaging, Locally advanced pancreatic cancer, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Meta-analysis, Internal medicine, Medicine, business
Published
2016

12. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: A Dutch national survey

Author

Djuna L. Cahen, Edmée C.M. Sikkens, Marco J. Bruno, Ernst J. Kuipers, Casper H.J. van Eijck, Gastroenterology & Hepatology, and Surgery

Subjects
Adult, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Weight loss, Internal medicine, Pancreatitis, Chronic, medicine, Humans, Enzyme Replacement Therapy, Prospective Studies, Pancreatitis, chronic, Exocrine pancreatic insufficiency, Pancreas, Aged, Netherlands, Hepatology, business.industry, Gastroenterology, Enzyme replacement therapy, Middle Aged, medicine.disease, Dietary Fats, Steatorrhea, Regimen, medicine.anatomical_structure, Endocrinology, Cross-Sectional Studies, Pancreatitis, Exocrine Pancreatic Insufficiency, Female, medicine.symptom, business
Abstract

Background: Treating exocrine pancreatic insufficiency with pancreatic enzymes is challenging because there is no fixed dose regimen. The required dose varies per patient, depending on the residual pancreatic function, the gut lumen physiology, and the fat content of each meal. Using a sufficient dose of enzymes is crucial to prevent weight loss, nutritional deficiencies, and to ameliorate steatorrhea-related symptoms. Data regarding the practise of enzyme replacement therapy are lacking. Therefore, we evaluated if patients with exocrine insufficiency caused by chronic pancreatitis receive proper treatment in the Netherlands. Methods: An anonymous survey was distributed to the members of the Dutch Association of Patients with Pancreatic Disorders. The survey focused on enzyme use, steatorrhea-related symptoms, dietary consultation, and food restrictions. Responding patients were included if they had chronic pancreatitis and were treated for exocrine insufficiency with pancreatic enzymes. Results: The survey was returned by 178 members who suffered from chronic pancreatitis, 161 of whom (90%) met the inclusion criteria. The mean age was 56 years and 53% were male. The median enzyme intake was 6 capsules per day and 25% of patients took 3 or less capsules. Remarkably, 70% of patients still reported steatorrhea-related symptoms, despite treatment. Only 25% of cases were referred to a dietician and 58% kept a restriction of fat (either instructed by a dietician or self-imposed). Conclusion: Many patients with exocrine insufficiency caused by chronic pancreatitis are under-treated in the Netherlands, a country with a well-organized healthcare system. To improve treatment efficacy, patients should be educated in adjusting the enzyme dosage according to steatorrhea-related symptoms and dietary fat intake. Moreover, patients should be referred to a well-trained, specialized dietician. Copyright (C) 2012, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier

Published
2012

13. Subject Index Vol. 9, 2009

Author

C.W. Imrie, S. George, Randall K. Pearson, Randall E. Brand, C. Davis, Michael J. Levy, C.D. Johnson, Mark Topazian, Hen-Hong Chang, Joy Chen, Martin E. Fernandez-Zapico, J.P. Neoptolemos, Darwin L. Conwell, Mats Lindblad, Rocio Lopez, Rachael Diamond, Bechien U. Wu, R. Sutton, Valentin Giroux, L.M. Smith, Casper H.J. van Eijck, Chien-An Chen, Bret T. Petersen, J. Jan B. van Lanschot, Lauren M. Smith, Tomas S Bexelius, M.E. Pasqualini, Patricia Zuccaro, Erin Fink, R.M. Pickering, Chung-Yu Kao, Jean-Charles Dagorn, Tung-Hu Tsai, D.P. Berry, Yu-Jen Chen, T.C. Khe Tran, Tyler Stevens, Elie Aoun, Luis A. García Rodríguez, David C. Whitcomb, Kathryn Repas, Timothy B. Gardner, Georgios I. Papachristou, S. Sharif, Jonathan E. Clain, Saima Sharif, S. Harris, Suresh T. Chari, Andrea Comba, Derek Reighard, Janette Lamb, Juan L. Iovanna, Ferga C. Gleeson, Santhi Swaroop Vege, Marco J. Bruno, Gwen Lomberk, and Michael G. Sarr

Subjects
Index (economics), Hepatology, business.industry, Endocrinology, Diabetes and Metabolism, Statistics, Gastroenterology, Medicine, Subject (documents), business
Published
2009

14. Catheter drainage versus relaparotomy for severe pancreatic fistula after pancreatoduodenectomy: A nationwide propensity-matched analysis

Author

Erwin van de Harst, Ignance de Hingh, Quintus Molenaar, Robbert A. E. Slooff, Jasmijn Smits, Hjalmar C. van Santvoort, Johanna A. M. G. Tol, David P J van Dijk, Koert P. de Jong, Olivier R. Busch, Casper H.J. van Eijck, Marilot C. T. Batenburg, Djamila Boerma, Inne H.M. Borel Rinkes, Sebastiaan Festen, and Ronald M. van Dam

Subjects
medicine.medical_specialty, Hepatology, Pancreatic fistula, business.industry, Endocrinology, Diabetes and Metabolism, Catheter drainage, Propensity score matching, Gastroenterology, medicine, medicine.disease, business, Surgery
Published
2015

15. Impact of a nationwide training program in laparoscopic distal pancreatectomy (LAELAPS)

Author

Casper H.J. van Eijck, Joost M. Klaase, Djamila Boerma, Jony van Hilst, Bert A. Bonsing, Pascal Steenvoorde, Quintus Molenaar, Michael F. Gerhards, Ronald M. van Dam, Geert Kazemier, Olivier R. Busch, Gijs A. Patijn, Freek Daams, Marc G. Besselink, Bas Groot Koerkamp, Daphne Roos, Jan H. Wijsman, Daan J. Lips, Misha D. P. Luyer, Sebastiaan Festen, Dirk J. Gouma, Marcel G. W. Dijkgraaf, Joris J. Scheepers, Mohammed Abu Hilal, Ignace H. J. T. de Hingh, Ruben H J de Kleine, George P. van der Schelling, Cornelis J. H. M. van Laarhoven, Thijs de Rooij, and Erwin van der Harst

Subjects
medicine.medical_specialty, Hepatology, biology, business.industry, Endocrinology, Diabetes and Metabolism, General surgery, Gastroenterology, Medicine, Laelaps, business, Training program, biology.organism_classification, Distal pancreatectomy
Published
2016

16. Laparoscopic versus open distal pancreatectomy for benign and malignant disease: A multicenter retrospective analysis

Author

Els J. M. Nieveen van Dijkum, Harry van Goor, Gijs A. Patijn, Quintus Molennaar, Casper H.J. van Eijck, Ignace de Hingh, Djamila Boerma, Marcel G. W. Dijkgraaf, Joris J. Scheepers, Jantien A. Vogel, Hjalmar C. van Santvoort, Michael F. Gerhards, Anneke P. J. Jilesen, Geert Kazemier, Erwin van der Harst, Olivier R. Busch, Egbert Sieders, George P. van der Schelling, Koop Bosscha, Thijs de Rooij, Marc G. Besselink, Bert A. Bonsing, Joost M. Klaase, and Ronald M. van Dam

Subjects
medicine.medical_specialty, Hepatology, business.industry, Endocrinology, Diabetes and Metabolism, Gastroenterology, medicine, Retrospective analysis, business, Distal pancreatectomy, Malignant disease, Surgery
Published
2014

17. Nationwide study on survival after distal pancreatectomy for pancreatic ductal adenocarcinoma

Author

Johanna A. M. G. Tol, Gijs A. Patijn, Quintus Molenaar, Joris J. Scheepers, Marcel G. W. Dijkgraaf, Michael F. Gerhards, Hjalmar C. van Santvoort, Casper H.J. van Eijck, Thijs de Rooij, Koop Bosscha, Ignace H. J. T. de Hingh, Bert A. Bonsing, Erwin van der Harst, Djamila Boerma, Marc G. Besselink, Geert Kazemier, Olivier R. Busch, Egbert Sieders, George P. van der Schelling, Ronald M. van Dam, Harry van Goor, and Joost M. Klaase

Subjects
Oncology, medicine.medical_specialty, Pancreatic ductal adenocarcinoma, Hepatology, business.industry, Endocrinology, Diabetes and Metabolism, Internal medicine, Gastroenterology, medicine, business, Distal pancreatectomy
Published
2015

18. Diagnosis and timing of intervention in infected necrotising pancreatitis: an international multidisciplinary survey and case vignette study

Author

Marcel G. W. Dijkgraaf, Hein G. Gooszen, Casper H.J. van Eijck, Krijn P. van Lienden, Paul Fockens, Kees Dejong, Thomas L. Bollen, Janneke van Grinsven, Harry van Goor, Marja A. Boermeester, Marc G. Besselink, Hjalmar C. van Santvoort, Olaf J. Bakker, Marco J. Bruno, Sandra van Brunschot, and Karen D. Horvath

Subjects
medicine.medical_specialty, Hepatology, Multidisciplinary approach, business.industry, Endocrinology, Diabetes and Metabolism, Intervention (counseling), Gastroenterology, Case vignette, Medicine, Necrotising pancreatitis, business, Intensive care medicine
Published
2014

19. Subject Index Vol. 8, 2008

Author

Magnus Nilsson, Raul Urrutia, Nanna M. Jensen, Shoji Fukuyama, Naoaki Sakata, Rory L. Smoot, Georg Feldmann, Maarten S. van Leeuwen, Ching-Chung Lin, Takuya Moriya, Shinichi Egawa, Nils Habbe, Chia-Yuan Liu, Thomas M. Gress, Malte Buchholz, Patrick C. Freeny, John Neoptolemos, Toru Furukawa, Wen-Hsiung Chang, Ming-Jen Chen, Andrei V. Ougolkov, H. Dujsikova, Marc G. Besselink, David B. Krizman, Karen D. Horvath, Cheng-Hsin Chu, J. Tomandl, M. Precechtelova, Santhi Swaroop Vege, Koenraad J. Mortele, A. Borgström, Brian L. Hood, Johan S. Laméris, J. Sadic, Jonathan P. Evans, Yu Katayose, Thomas L. Bollen, Yu-Jen Chen, Anirban Maitra, Thomas C. Smyrk, Hein G. Gooszen, A. Sevcikova, Michael G. Sarr, Masaharu Ishida, William Greenhalf, Gwen Lomberk, Hans A. Kestler, Thomas P. Conrads, Wang Cheung, Tadayoshi Abe, David M. Hough, P. Dítě, Akira Horii, Takeshi Aoki, Tsang-En Wang, Jan Mollenhauer, Rahul Pannala, John J. Hermans, J. Manjer, C. Hjalmarsson, Lars Grenacher, Marja A. Boermeester, Mariza de Andrade, Mark J. Truty, Gloria M. Petersen, Hjalmar C. van Santvoort, Makoto Sunamura, Ricardo A. Cruciani, Suresh Pitchumoni, Supot Pongprasobchai, Casper H.J. van Eijck, Detlef K. Bartsch, Michiaki Unno, Jens Werner, John P. Neoptolemos, Suresh T. Chari, Hector A Alvarez, William R. Bamlet, S. Appelros, Shou-Chuan Shih, Peter A. Banks, Núria Malats, Marlene Darfler, S. Regnér, Steen Larsen, Yukio Mikami, Fuyuhiko Motoi, Martin E. Fernandez-Zapico, and Kei Kawaguchi

Subjects
Index (economics), Hepatology, business.industry, Endocrinology, Diabetes and Metabolism, Statistics, Gastroenterology, Medicine, Subject (documents), business
Published
2008

20. Preoperative characteristics of patients with presumed pancreatic cancer but ultimately benign disease: A multicenter series of 344 pancreatoduodenectomies

Author

Ignace H. J. T. de Hingh, Bert A. Bonsing, Olivier R. Busch, Inne H.M. Borel Rinkes, Koert P. de Jong, I. Quintus Molenaar, Ronald M. van Dam, Arja Gerritsen, Marc G. Besselink, Harry van Goor, Dirk J. Gouma, Michael F. Gerhards, Marcel G. W. Dijkgraaf, Erwin van der Harst, Hjalmar C. van Santvoort, Bert van Ramshorst, Casper H.J. van Eijck, Thomas L. Bollen, G. Johan A. Offerhaus, Egbert Sieders, and C. Yung Nio

Subjects
medicine.medical_specialty, Hepatology, Benign disease, business.industry, Endocrinology, Diabetes and Metabolism, General surgery, Pancreatic cancer, Gastroenterology, medicine, medicine.disease, business
Published
2013

Catalog

Books, media, physical & digital resources
See catalog results